LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Is Raising Ascendis Pharma A/S (ASND) Q3 25 Rev. Estimate To 134.3 M From 133.7 M 1/16/2025 10:29:53 AM
  • Wedbush Is Cutting Ascendis Pharma A/S (ASND) Q2 25 Rev. Estimate To 112.2 M From 114.1 M 1/16/2025 10:29:42 AM
  • Wedbush Is Lowering Ascendis Pharma A/S (ASND) Q1 25 Rev. Estimate To 92.5 M From 97.6 M 1/16/2025 10:29:32 AM
  • Wedbush Is Increasing Ascendis Pharma A/S (ASND) FY24 Rev. Estimate To 363.7 M From 276.7 M 1/16/2025 10:29:22 AM
  • Wedbush Is Increasing Ascendis Pharma A/S (ASND) Q4 24 Rev. Estimate To 174.0 M From 86.9 M 1/16/2025 10:29:11 AM
  • Wedbush Is Cutting Ascendis Pharma A/S (ASND) FY25 Estimate To -4.00 From -3.92 1/16/2025 10:28:49 AM
  • Wedbush Is Raising Ascendis Pharma A/S (ASND) Q4 25 Estimate To -0.61 From -0.64 1/16/2025 10:28:36 AM
  • Wedbush Is Lowering Ascendis Pharma A/S (ASND) Q2 25 Estimate To -1.03 From -1.00 1/16/2025 10:27:35 AM
  • Wedbush Is Cutting Ascendis Pharma A/S (ASND) Q1 25 Estimate To -1.53 From -1.46 1/16/2025 10:27:21 AM
  • Wedbush Is Raising Ascendis Pharma A/S (ASND) FY24 Estimate To -6.21 From -7.37 1/16/2025 10:27:10 AM
  • Wedbush Is Raising Ascendis Pharma A/S (ASND) Q4 24 Estimate To -0.27 From -1.43 1/16/2025 10:26:58 AM
  • Wedbush Is Lowering Ascendis Pharma A/S (ASND) FY25 Rev. Estimate To 497.8 M From 583.4 M 11/15/2024 8:25:15 AM
  • Wedbush Is Lowering Ascendis Pharma A/S (ASND) Q4 25 Rev. Estimate To 152.4 M From 194.5 M 11/15/2024 8:24:58 AM
  • Wedbush Is Cutting Ascendis Pharma A/S (ASND) Q3 25 Rev. Estimate To 133.7 M From 154.8 M 11/15/2024 8:24:46 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap